Clinical Trials Browser

INDUSTRY × capivasertib × Clear all

Healthy Participants

Moderate Hepatic Impairment

Breast Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Disease Progression

Locally Advanced (Inoperable) or Metastatic Breast Cancer

Breast Neoplasms, Melanoma

Healthy Participants

Breast Neoplasms, Triple Negative Breast Neoplasms

Locally Advanced (Inoperable) or Metastatic Breast Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Uterine Cervical Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Solid Tumour

Advanced Solid Tumours

Neoplasm Metastasis, Prostatic Neoplasms

Hematologic Neoplasms

Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)

Advanced Solid Malignancy,

Advanced Solid Malignancy

Clinical Trials

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants

A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment

CAPItana

ReDiscover-2

CAPItello-281

CAPItrue

CAPItello-292

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants

BEGONIA

CAPItello-291

SERENA-1

ELEVATE

CAPItello-290

DB-08

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

CAPItello280

CAPITAL

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

Capivasertib China PK Study

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

OAK

Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies